Results for tag: "Almitrine"

Almitrine is a respiratory drug used to treat chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it helps to open up the airways and improve breathing. Almitrine is usually taken in combination with other drugs, such as corticosteroids, to help reduce inflammation and improve breathing. It is available in both oral and injectable forms. Almitrine is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2019. It is currently marketed by several pharmaceutical companies, including GlaxoSmithKline, AstraZeneca, and Boehringer Ingelheim. The Almitrine market is growing rapidly, as COPD is a major health concern in many countries. It is expected to continue to grow in the coming years, as more people are diagnosed with COPD and the need for effective treatments increases. Some companies in the Almitrine market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck, and Novartis. Show Less Read more